Perez-SanJose, D.; de la Fuente, M.A.; Serna Pérez, J.; Simarro, M.; Eiros Bouza, J.M.; Sanz-Muñoz, I.
CRISPR/CasRx Proof-of-Concept for RNA Degradation: A Future Tool against RNA Viruses? Pharmaceuticals 2022, 15, 32.
https://doi.org/10.3390/ph15010032
AMA Style
Perez-SanJose D, de la Fuente MA, Serna Pérez J, Simarro M, Eiros Bouza JM, Sanz-Muñoz I.
CRISPR/CasRx Proof-of-Concept for RNA Degradation: A Future Tool against RNA Viruses? Pharmaceuticals. 2022; 15(1):32.
https://doi.org/10.3390/ph15010032
Chicago/Turabian Style
Perez-SanJose, Diana, Miguel Angel de la Fuente, Julia Serna Pérez, Maria Simarro, José MarÃa Eiros Bouza, and Ivan Sanz-Muñoz.
2022. "CRISPR/CasRx Proof-of-Concept for RNA Degradation: A Future Tool against RNA Viruses?" Pharmaceuticals 15, no. 1: 32.
https://doi.org/10.3390/ph15010032
APA Style
Perez-SanJose, D., de la Fuente, M. A., Serna Pérez, J., Simarro, M., Eiros Bouza, J. M., & Sanz-Muñoz, I.
(2022). CRISPR/CasRx Proof-of-Concept for RNA Degradation: A Future Tool against RNA Viruses? Pharmaceuticals, 15(1), 32.
https://doi.org/10.3390/ph15010032